497 related articles for article (PubMed ID: 9723818)
1. Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers.
Ouellet D; Hsu A; Qian J; Locke CS; Eason CJ; Cavanaugh JH; Leonard JM; Granneman GR
Br J Clin Pharmacol; 1998 Aug; 46(2):111-6. PubMed ID: 9723818
[TBL] [Abstract][Full Text] [Related]
2. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.
Rosenfeld WE; Doose DR; Walker SA; Nayak RK
Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594
[TBL] [Abstract][Full Text] [Related]
3. The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives.
Sinofsky FE; Pasquale SA
Am J Obstet Gynecol; 1998 Feb; 178(2):300-4. PubMed ID: 9500490
[TBL] [Abstract][Full Text] [Related]
4. Effects of ABT-761, a novel 5-lipoxygenase inhibitor, on the pharmacokinetics of a single dose of ethinyl estradiol and levonorgestrel in healthy female volunteers.
Wong SL; O'Dea RF; Dube LM; Awni WM
J Clin Pharmacol; 1998 Jul; 38(7):642-8. PubMed ID: 9702850
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of a triphasic oral contraceptive containing desogestrel and ethinyl estradiol.
Archer DF; Timmer CJ; Lammers P
Fertil Steril; 1994 Apr; 61(4):645-51. PubMed ID: 8150105
[TBL] [Abstract][Full Text] [Related]
6. An investigation into the effect of tenidap sodium on the pharmacokinetics of a combined oral contraceptive.
Coates PE; Mesure R
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):47S-50S. PubMed ID: 7547095
[TBL] [Abstract][Full Text] [Related]
7. Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis.
Price TM; Dupuis RE; Carr BR; Stanczyk FZ; Lobo RA; Droegemueller W
Am J Obstet Gynecol; 1993 May; 168(5):1400-6. PubMed ID: 8498419
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: serum protein binding of gestodene and influence of treatment on free and total testosterone levels in the serum.
Kuhnz W; Baumann A; Staks T; Dibbelt L; Knuppen R; Jütting G
Contraception; 1993 Oct; 48(4):303-22. PubMed ID: 8222659
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of cyproterone acetate and ethinylestradiol in 15 women who received a combination oral contraceptive during three treatment cycles.
Kuhnz W; Staks T; Jütting G
Contraception; 1993 Dec; 48(6):557-75. PubMed ID: 8131397
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of single and multiple doses of ethinyl estradiol and levonorgestrel in relation to smoking.
Kanarkowski R; Tornatore KM; D'Ambrosio R; Gardner MJ; Jusko WJ
Clin Pharmacol Ther; 1988 Jan; 43(1):23-31. PubMed ID: 3121231
[TBL] [Abstract][Full Text] [Related]
11. Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol.
Eldon MA; Underwood BA; Randinitis EJ; Sedman AJ
Neurology; 1998 Apr; 50(4):1146-8. PubMed ID: 9566412
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum.
Kuhnz W; Staks T; Jütting G
Contraception; 1994 Dec; 50(6):563-79. PubMed ID: 7705098
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation.
Kuhnz W; al-Yacoub G; Fuhrmeister A
Contraception; 1992 Nov; 46(5):455-69. PubMed ID: 1458892
[TBL] [Abstract][Full Text] [Related]
14. Effect of vicriviroc with or without ritonavir on oral contraceptive pharmacokinetics: a randomized, open-label, parallel-group, fixed-sequence crossover trial in healthy women.
Kasserra C; Li J; March B; O'Mara E
Clin Ther; 2011 Oct; 33(10):1503-14. PubMed ID: 22015327
[TBL] [Abstract][Full Text] [Related]
15. Single and multiple administration of a new triphasic oral contraceptive to women: pharmacokinetics of ethinyl estradiol and free and total testosterone levels in serum.
Kuhnz W; Sostarek D; Gansau C; Louton T; Mahler M
Am J Obstet Gynecol; 1991 Sep; 165(3):596-602. PubMed ID: 1892184
[TBL] [Abstract][Full Text] [Related]
16. Effects of ritonavir-boosted protease inhibitors on combined oral contraceptive pharmacokinetics and pharmacodynamics in HIV-positive women.
Barcellos T; Natavio M; Stanczyk FZ; Luo D; Jusko WJ; Bender NM
Contraception; 2019 Oct; 100(4):283-287. PubMed ID: 31194965
[TBL] [Abstract][Full Text] [Related]
17. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
Griffith SG; Dai Y
Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic interaction between ethinyl estradiol, norethindrone and darunavir with low-dose ritonavir in healthy women.
Sekar VJ; Lefebvre E; Guzman SS; Felicione E; De Pauw M; Vangeneugden T; Hoetelmans RM
Antivir Ther; 2008; 13(4):563-9. PubMed ID: 18672535
[TBL] [Abstract][Full Text] [Related]
19. Can oral contraceptive steroids influence the elimination of nifedipine and its primary pryidine metabolite in humans?
Balogh A; Gessinger S; Svarovsky U; Hippius M; Mellinger U; Klinger G; Hoffmann A; Oettel M
Eur J Clin Pharmacol; 1998; 54(9-10):729-34. PubMed ID: 9923576
[TBL] [Abstract][Full Text] [Related]
20. Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics.
Stoehr GP; Kroboth PD; Juhl RP; Wender DB; Phillips JP; Smith RB
Clin Pharmacol Ther; 1984 Nov; 36(5):683-90. PubMed ID: 6149030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
